Enhertu showed improved iDFS over Kadcyla in early-stage HER2-positive breast cancer with residual disease post-neoadjuvant ...

Michael Wang, MD, professor at The University of Texas MD Anderson Cancer Center, details the rationale for a long-term ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

Researchers say the drug likely increases the risk of serious side effects, including heart disease, and that its potential ...

Menu Price Action -- Good Times core menu prices have increased about 1% since January 2024, with minimal premium to competitors; Bad Daddy’s anticipates less than 1% blended year-over-year pricing ...

The latest announcement is out from Trinity Biotech ( (TRIB) ).

Adtran posts segment growth but weak earnings, rising receivables, bearish technicals and limited upside under a leveraged ...

For much of the last two years, multi-agent systems have been treated as the natural next step in artificial intelligence. If one large language model can reason, plan, and act, then several working ...

Investigators assessed long-term PFS and safety results for acalabrutinib, bendamustine, and rituximab in the phase 3 ECHO trial.

The researchers found single AI agents do better at sequential tasks, multi-agent workflows at ones that can be done in ...

This is a preview. Log in through your library . Abstract Suppose that a clinical trial has been carried out using a sequential design. Any analysis that neglects the monitoring of the trial is ...

An Osaka Metropolitan University research team conducted a study that proposes a transparent multi-task framework that combines a multi-slot user memory with a dynamic gating network to jointly ...